You have accessJournal of UrologyCME1 Apr 2023MP76-09 SCHELIN CATHETERTM FOR TRANS URETHRAL INTRAPROSTATIC ANESTHESIA BEFORE REZŪM WATER VAPOR TREATMENT: A NEW TOOL TO ENHANCE THE MINIMAL INVASIVENESS Giampaolo Siena, Francesco Sessa, Paolo Polverino, Lorenzo Viola, Anna Rivetti, Pietro Spatafora, Riccardo Campi, and Luca Cindolo Giampaolo SienaGiampaolo Siena More articles by this author , Francesco SessaFrancesco Sessa More articles by this author , Paolo PolverinoPaolo Polverino More articles by this author , Lorenzo ViolaLorenzo Viola More articles by this author , Anna RivettiAnna Rivetti More articles by this author , Pietro SpataforaPietro Spatafora More articles by this author , Riccardo CampiRiccardo Campi More articles by this author , and Luca CindoloLuca Cindolo More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003350.09AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Among minimally invasive surgical techniques (MISTs) for moderate lower urinary tract symptoms (LUTS) due to benign prostatic obstruction (BPO), RezūmTM water vapor treatment (Boston Scientific Corporation, Marlborough, USA) (RT) has been accepted as one of the most effective and versatile, with a very good sexual safety profile. To further enhance the minimal invasiveness of RT, we sought to evaluate potential advantages and feasibility of pure local transurethral intraprostatic anesthesia (TUIA) via the Schelin CatheterTM (ProstaLund AB, Lund, Sweden) (SC), a 3 ways device designed with an operational channel equipped with a retractile needle and the standard drainage and ballon ports (Figure 1). METHODS: After Ethical Commitee approval, included and collected data from 20 patients with moderate LUTS due to BPO, undergone RT procedure using TUIA by SC, from 2 centers. To rate their pain, patients were asked to use a numeric rating scale (NSR; numbered 0–10; 0 “No pain”/10 “Worst pain”) at 9-time points: 1-Preoperatively; 2-Schelin catheter insertion; 3-anestethic infiltration; 4-Rezum probe insertion; 5-Water Vapor Treatment (WVT); 6-Catheter insertion; 7-Day 1; 8-Day 7 catheter removal; 9-Day 30 follow-up visit. RESULTS: All 20 patients safely received TUIA prior RT. None required further anesthesiologic treatment. Median prostate size, Qmax, IPSS and QoL were 7 5ml, 9 mL/sec, 23 and 4, respectively. Median TUIA time was 3 minutes. Median catheterization time was 7 days. No need of re-catheterization or urinary tract infections at 30 days post-operatively were reported. Median NRS reported was 1.5 at each time point except at point 1, 2, 3 and 5. At preoperative stage NRS of pain was 0 in all cases. During catheter insertion (point 2) median NRS of pain was 2; during LA infiltration (point 3) was 2.5, and during WVT was 2 (point 5). One out of 10 patients reported a NRS of 6 during WVT (point 5). No perioperative anesthesiologic and procedure-related complications were recorded. CONCLUSIONS: Our data report for the first time in literature the feasibility and safeness of TUIA during RT using SC that showed full operative and post-operative pain control and reduced operative time and patient discomfort. Source of Funding: none © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e1094 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Giampaolo Siena More articles by this author Francesco Sessa More articles by this author Paolo Polverino More articles by this author Lorenzo Viola More articles by this author Anna Rivetti More articles by this author Pietro Spatafora More articles by this author Riccardo Campi More articles by this author Luca Cindolo More articles by this author Expand All Advertisement PDF downloadLoading ...
Read full abstract